MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease

N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)

Meeting: MDS Virtual Congress 2020

Abstract Number: 393

Keywords: Anxiety, Cognitive dysfunction, Parkinsonism dementia complex(PDC)

Category: Parkinson's Disease: Cognitive functions

Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.

Background: Cognitive impairment and anxiety are top rated concerns in persons with Parkinson’s disease (PWP). Dementia is evident in 80% of PWP at advanced disease. Emerging evidence suggests that patients with anxiety are 3 times more likely to present with mild cognitive impairment (MCI) in PD, which is a prodromal state of dementia [1]. Preliminary evidence has demonstrated a link between memory impairment and anxiety in PWP.

Method: The present study aimed to further investigate this association using the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for anxiety disorders and a comprehensive standardised cognitive test battery. The cognitive test battery (N = 82) consisted two tests from each of the following cognitive domains: memory, attention/working memory, executive function, visuospatial and language. Logistic regression models adjusted for age and gender were constructed to identify cognitive characteristics associated with anxiety disorders compared to no anxiety.

Results: PWP with DSM-5 anxiety disorders compared to those without anxiety demonstrated both immediate (Odds ratio = 0.44, 95% CI = 0.24–0.81, p < 0.01) and delayed recall (Odds ratio = 0.59, 95% CI = 0.37–0.96, p = 0.03) verbal memory impairment.

Conclusion: These findings present first evidence that anxiety is associated with verbal memory impairment in PD. Further investigations are warranted to understand the neurobiological underpinnings of this association between anxiety and memory impairment in PWP without dementia, and the contribution of anxiety towards future progression to dementia in PWP.

References: [1] Dissanayaka et. al. [ICICLE-PD study group] Parkinsonism & Related Disorders (2017). Anxiety is associated with cognitive impairment in Parkinson’s disease.

To cite this abstract in AMA style:

N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne. Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/anxiety-disorders-are-associated-with-verbal-memory-impairment-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/anxiety-disorders-are-associated-with-verbal-memory-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley